术前乳腺MR成像及MR引导手术对伴与不伴DCIS成分的浸润性乳腺癌女性诊断及手术结局的影响
前瞻性两中心研究纳入593例活检证实的浸润性乳腺癌患者,比较乳腺MR成像与常规成像(数字乳腺X线摄影和乳腺超声)对DCIS成分的诊断准确性,并探讨术前MR成像联合MR引导穿刺活检和/或病灶定位对手术结局的影响。结果显示MR成像对DCIS成分的敏感度显著高于常规成像(84.9% vs 36.7%,P < .0001),且切缘阳性率和乳房切除术率总体较低,与有无DCIS成分无关。
要点
- MR成像对浸润性乳腺癌中DCIS成分的术前诊断敏感度84.9%,显著高于常规成像的36.7%(P < .0001)。
- 51.1%(71/139)的DCIS成分仅由MR成像检出,常规成像未显示。
- 切缘阳性率总体3.7%,有DCIS成分者5.0%与无DCIS成分者3.3%无显著差异。
核心结论
- 乳腺MR成像可改善浸润性乳腺癌术前DCIS成分的显示,且无论是否存在DCIS成分,切缘阳性率和乳房切除术率均较低。
研究设计与样本
- 前瞻性两中心研究,连续纳入593例活检证实的浸润性乳腺癌患者,均行乳腺MR成像及常规成像(数字乳腺X线摄影和乳腺超声);对仅MR可见的DCIS成分行MR引导真空活检和MR引导病灶定位或标记;以手术病理为参考标准。
关键影像表现/征象
- 手术病理显示139/593例(23.4%)存在DCIS成分。
- MR成像对DCIS成分的敏感度84.9%(118/139),常规成像为36.7%(51/139),P < .0001。
- 51.1%(71/139)的DCIS成分仅由MR成像检出。
诊断标准与关键数值
- MR成像对DCIS成分的敏感度84.9%(118/139) vs 常规成像36.7%(51/139),P < .0001。
- 小、边缘性DCIS成分:MR敏感度56.8%(21/37) vs 常规29.7%(11/37)。
- 广泛性DCIS成分:MR敏感度91.7%(55/60) vs 常规41.7%(25/60)。
- 大、主导性DCIS成分:MR敏感度100.0%(42/42) vs 常规35.7%(15/42)。
- 低级别DCIS成分:MR敏感度74.0%(20/27) vs 常规40.7%(11/27)。
临床应用与阅片要点
- 术前乳腺MR成像可提高对浸润性乳腺癌中DCIS成分的检出,尤其是仅MR可见的DCIS成分。
- 对仅MR可见的DCIS成分行MR引导真空活检和/或MR引导病灶定位或标记。
- 切缘阳性率总体3.7%(95% CI: 2.3%, 5.6%),有DCIS成分者5.0%(95% CI: 2.0%, 10.1%),无DCIS成分者3.3%(95% CI: 1.9%, 5.4%),两组间无显著差异。
- 乳房切除术率有DCIS成分者10.8%(95% CI: 6.2%, 17.2%),无DCIS成分者8.1%(95% CI: 5.8%, 11.1%),两组间无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To (a) compare the diagnostic accuracy of breast magnetic resonance (MR) imaging with that of conventional imaging (digital mammography and breast ultrasonography) in the identification of ductal carcinoma in situ (DCIS) components of biopsy-proven invasive breast cancer before surgery and (b) investigate the surgical outcome (positive margin rates and mastectomy rates) of women with breast cancer who underwent preoperative MR imaging combined with MR-guided needle biopsy and/or MR-guided lesion localization or bracketing where appropriate. Materials and Methods The authors performed a prospective two-center study of 593 consecutive patients with biopsy-proven invasive breast cancer who underwent breast MR imaging in addition to conventional imaging. MR-guided vacuum biopsy and MR-guided lesion bracketing were performed for DCIS components visible at MR imaging alone. The accuracy of breast MR imaging was compared with that of conventional imaging, and surgical outcomes (positive margin and mastectomy rates) were investigated. Results Surgical-pathologic assessment demonstrated DCIS components in 139 of the 593 women (23.4%). The sensitivity of MR imaging for the diagnosis of DCIS components pre-operatively (84.9%; 118 of 139) was significantly higher than that of conventional imaging (36.7%; 51 of 139) (P < .0001); more than half of DCIS components (51.1%; 71 of 139) were detected only with MR imaging. The sensitivity advantage of MR imaging over conventional imaging increased with increasing relative size of DCIS components, as follows: The sensitivity of MR imaging versus conventional imaging for small, marginal DCIS components was 56.8% (21 of 37) versus 29.7% (11 of 37); the sensitivity for extensive DCIS components was 91.7% (55 of 60) versus 41.7% (25 of 60); the sensitivity for large, predominant DCIS components was 100.0% (42 of 42) versus 35.7% (15 of 42). Moreover, the sensitivity advantage of MR imaging over conventional imaging increased with increasing nuclear grade of DCIS components, as follows: The sensitivity of MR imaging versus conventional imaging for low-grade DCIS components was 74.0% (20 of 27) versus 40.7% (11 of 27); the sensitivity for intermediate-grade DCIS components was 84.1% (53 of 63) versus 34.9% (22 of 63); the sensitivity for high-grade DCIS components was 91.8% (45 of 49) versus 36.7% (18 of 49) (P < .05-.001 for all). Positive margin rates were low overall (3.7% [95% Clopper Pearson confidence interval [CI]: 2.3%, 5.6%]) and did not differ significantly between the 139 women with DCIS components (5.0% [95% CI: 2.0%, 10.1%]) compared with the 454 women without such components (3.3% [95% CI: 1.9%, 5.4%]). The same was true for mastectomy rates (10.8% [95% CI: 6.2%, 17.2%] vs 8.1% [95% CI: 5.8%, 11.1%]). Conclusion Breast MR imaging improves depiction of DCIS components of invasive breast cancers before surgery and is associated with positive margin and mastectomy rates that are low irrespective of the presence or absence of DCIS components. © RSNA, 2017.
引用
- Kuhl CK, Strobel K, Bieling H, et al. Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component. Radiology. 2017. PMID: 28445683. doi:10.1148/radiol.2017161449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。